Avalon GloboCare Corp. Logo

Avalon GloboCare Corp.

Develops cell-based immunotherapies and provides precision diagnostics and lab services.

ALBT | US

Overview

Corporate Details

ISIN(s):
US05344R3021 (+1 more)
LEI:
Country:
United States of America
Address:
4400 ROUTE 9, 7728 FREEHOLD

Description

Avalon GloboCare Corp. is a commercial-stage company dedicated to developing and delivering transformative healthcare solutions. The company's activities are centered on two main areas: advancing cell-based immunotherapies and providing precision diagnostics with clinical laboratory services. Its therapeutic development focuses on immune effector cell therapies, including Chimeric Antigen Receptor T-cell (CAR-T) technology. In diagnostics, its core technology platforms include the KetoAir™ breathalyzer, which utilizes nanosensor technology, and the QTY protein design platform, a joint intellectual property with the Massachusetts Institute of Technology (MIT). The company also operates clinical laboratories offering an extensive menu of services, such as general bloodwork, anatomic pathology, urine toxicology, and pharmacogenomics (PGx) testing.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Avalon GloboCare Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Avalon GloboCare Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Avalon GloboCare Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.